[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
February 23, 2011

IDSA Creates MRSA Treatment Guideline

JAMA. 2011;305(8):768-769. doi:10.1001/jama.2011.174

A new guideline on the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections issued by the Infectious Diseases Society of America (IDSA) provides physicians with detailed recommendations on how to treat various types of MRSA infections, including information on dosing of antibiotics when necessary.

The guideline was published January 5 and provides a detailed resource for physicians treating MRSA infections, ranging from uncomplicated skin infections to infective endocarditis, and provides specific recommendations on the care of pediatric patients with such infections (Liu C et al. Clin Infect Dis. 2011;52[3]:285-322). The guideline was drafted by a panel of infectious disease experts, including individuals with expertise in emergency department care and pediatrics, and reviews the evidence on each covered topic.